Showing 2981-2990 of 5771 results for "".
- Zeiss Launches Micor 700 Lens Extraction Devicehttps://modernod.com/news/zeiss-launches-micor-700-lens-extraction-device/2482459/Zeiss announced the US launch of the Micor 700 lens extraction device, which is designed to eliminate the need for ultrasound, offering a more sustainable and cost-effective solution while expanding the intraocular working space for surgeons. The Micor 700 will debut
- Aurion Biotech Launches Vyznova in Japan, the First Cell Therapy for Corneal Endothelial Diseasehttps://modernod.com/news/aurion-biotech-launches-vyznova-in-japan-the-first-cell-therapy-for-corneal-endothelial-disease/2482458/Aurion Biotech announced the commercial launch of Vyznova (neltependocel) in Japan. Vyznova is the first approved cell therapy for the treatment of the corneal endothelial disease, bullous keratopathy. The therapy has received both regulatory and reimbursement approval in Japa
- Hoya Highlights the Impact Rural vs Urban Living Environments May Have On Myopia In Young Childrenhttps://modernod.com/news/hoya-highlights-the-impact-rural-vs-urban-living-environments-may-have-on-myopia-in-young-children/2482457/Hoya Vision Care announced the results of a 5-year epidemiological study conducted in Scotland exploring the correlations between myopia, socio-economic deprivation, and urban or rural dwellings in young children. The study, which reviewed refractive error data from eye examinations in
- Aviceda Completes Enrollment for Phase 2b SIGLEC Study for Geographic Atrophy Treatmenthttps://modernod.com/news/aviceda-completes-enrollment-for-phase-2b-siglec-study-for-geographic-atrophy-treatment/2482456/Aviceda Therapeutics announced the completion of patient enrollment for its phase 2b SIGLEC study. The trial is comparing the safety and efficacy of the company's lead candidate, AVD-104, with avacincaptad pegol (marketed as Izervay) for the treatment of geographic atrophy (GA) secondary to a
- Neuro-Optometric Rehabilitation Association Appoints Barbara Barclay as New Executive Directorhttps://modernod.com/news/neuro-optometric-rehabilitation-association-appoints-barbara-barclay-as-new-executive-director/2482455/The Neuro-Optometric Rehabilitation Association, International (NORA), has announced the appointment of Barbara Barclay as its new executive director, effective October 1. Ms. Barclay, an expert in eye-tracking technology and health tech, brings more than 30 years of leadership experience, i
- Lumibird Unveils Omnicad Imaging Platform for Ocular Surface Diseasehttps://modernod.com/news/lumibird-unveils-omnicad-imaging-platform-for-ocular-surface-disease/2482453/Lumibird Medical announced the launch of the Omnicad, an imaging platform equipped with integrated AI algorithms designed to aid in the diagnosis of ocular surface disease (OSD). The device, exclusively available in the US market, aims to address the needs of optometrists and ophthalmol
- Staar Opens New Experience Center to Meet Growing Surgeon Demandhttps://modernod.com/news/staar-opens-new-experience-center-to-meet-growing-surgeon-demand/2482452/Staar Surgical announced the expansion of its Staar Surgical Experience Center near John Wayne Airport (SNA) in Lake Forest, California. The new center aims to provide comprehensive, hands-on training and education in lens-based vision correction. Staar says the 
- CHMP Upholds Negative Opinion for Apellis' Pegcetacoplan for GA in the EU Following Re-Examinationhttps://modernod.com/news/chmp-upholds-negative-opinion-for-apellis-pegcetacoplan-for-geographic-atrophy-in-the-eu-following-re-examination/2482450/Apellis Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has upheld its previous June 2024 negative opinion on the marketing authorization application for geographic atrophy (GA) treatment pegcetacoplan.
- Visionix USA Introduces Topography Module for Optovue Solix OCT Systemshttps://modernod.com/news/visionix-usa-introduces-groundbreaking-topography-module-for-optovue-solix-oct-systems/2482448/Visionix USA announced the introduction of its new Topography Module for the Optovue Solix FullRange and Solix Essential OCT/OCT-A systems. This feature integrates topography with OCT and OCT-A, making the Optovue Solix systems a multimodal solution for comprehensive eye assessments.
- Opthea Completes Manufacturing Milestone for Wet AMD Treatmenthttps://modernod.com/news/opthea-completes-manufacturing-milestone-for-wet-amd-treatment/2482447/Opthea announced the successful completion of its drug substance Process Performance Qualification (PPQ) campaign for sozinibercept, its lead candidate for treating wet age-related macular degeneration (AMD). The PPQ campaign involved the production of three consecutive commercial-scale